$0.36
▲ +2.0% Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers
Overview
52-week range
$0.35
$78
0% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $5.17 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $2.88 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-4.32 | — | — | — | — | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $274.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $197.80 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $12.29 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.78 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $6.54 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-3M | $-2M | $-8M | $-1M | $-1M | $-731,000 |
| Net income | $-4M | — | $-3M | $-3M | $-12M | $-1M | $-1M | $-809,000 |
| EPS (diluted) | $5.17 | — | $2.88 | $43.19 | $274.25 | $197.80 | $12.29 | $0.78 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $6M | $9M | $3M | $2M | $2M | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $7M | $11M | $5M | $3M | $2M | — | — |
| Total assets | $4M | $7M | $12M | $6M | $3M | $2M | $4M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $5M | $5M | $6M | $8M | $2M | — | — |
| Total equity | $44,000 | $3M | $7M | $120,000 | $-5M | $153,000 | $2M | $-5M |
Implied volatility — last 90 days
No IV snapshots yet for SLXN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.